retatrutide eli lilly press release 2024 2025 Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial Clinical trials show promising results
Pay in 4 interest-free payments of $7.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28


























